Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.03 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.04 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.05 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |